<--- Back to Details
First PageDocument Content
Chemistry / Clinical pharmacology / Therapeutics / United States Public Health Service / New Drug Application / Carbinoxamine / Pharmaceutical sciences / Food and Drug Administration / Pharmacology
Date: 2004-01-06 18:55:53
Chemistry
Clinical pharmacology
Therapeutics
United States Public Health Service
New Drug Application
Carbinoxamine
Pharmaceutical sciences
Food and Drug Administration
Pharmacology

Add to Reading List

Source URL: www.fda.gov

Download Document from Source Website

File Size: 218,95 KB

Share Document on Facebook

Similar Documents

April 16, 2018 American Herbal Pharmacopoeia® and Therapeutic Compendium Standards of Analysis, Quality Control, and Therapeutics AHP Releases Monograph Standards, Motherwort Aerial Parts (Leonurus cardiaca; Leonurus qu

DocID: 1voig - View Document

Initiating Coverage December 18, 2014 InVivo Therapeutics (NVIV) Initiation Report

DocID: 1vapl - View Document

  Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors CAMBRIDGE, Mass., October 17, 2016 – Warp Drive Bio, a life sciences company developing therapeutics that exploit the molecules and mechanisms of

DocID: 1v3IN - View Document

Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference CAMBRIDGE, Mass., March 13, Warp Drive Bio, Inc., a drug discovery company developing therapeutics that exploit the molecules and

DocID: 1v3kf - View Document

Terms of Use Welcome to www.daytrana.com, a website owned by Noven Pharmaceuticals, Inc. This website is produced by Noven Therapeutics LLC. The information provided on this site is for general information and educationa

DocID: 1v0Hj - View Document